Contract grant sponsor National Natural Science Foundation of China; Contract grant
number: 81260214. Background Recent studies have highlighted the diagnostic value of …

A type of sorafenib‐(SOR‐) loaded long‐circulating nanoliposome was constructed, and the
targeting performance and antitumor effects of the prepared liposome were evaluated in the …

Sonazoid is a new ultrasound contrast agent with unique Kupffer phase imaging advantages
and high mechanical index stability. This paper introduces the basic theories and …

Background The antitumor effect of a drug is considered to be associated with a decrease in
tumor blood flow. Aims We investigated whether the efficacy of lenvatinib (LEN) could be …

This article continues a previously published review,“3D ultrasound: Current state, emerging
trends and technologies,” which was the first part in a cycle addressing 3D/4D ultrasound …

Статья продолжает опубликованный ранее обзор «Трехмерное ультразвуковое
исследование: технологии, тенденции развития», являющийся первой работой из …

Aim This study aims to evaluate the efficacy and safety of lenvatinib radiofrequency ablation
(RFA) sequential therapy for certain hepatocellular carcinoma (HCC) patients. Methods One …

Background Contrast-enhanced ultrasonography (CE-US) brings a higher signal-to-noise
ratio and a higher sensitivity for slow flow than traditional B-mode ultrasonography (US) …

Imaging biomarkers of early response to cancer therapy can facilitate more effective
treatment adaptation and improve cancer management. These biomarkers can detect …